Evidence map›Paper›PMID 41805250›Full record

ArticleClinical nuclear medicine2026

18 F-FDG Outperforms 18 F-FAPI-04 in Detecting Primary Splenic Angiosarcoma and Its Metastatic Lesions in Liver.

Dongze Li, Zhina Wang, Bingbing Ran, Aisheng Dong, Hongguang Zhao

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical nuclear medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dongze LiDepartment of Nuclear Medicine, The First Hospital of Jilin University, Changchun, Jilin Province.
Zhina WangDepartment of Nuclear Medicine, The First Hospital of Jilin University, Changchun, Jilin Province.
Bingbing RanDepartment of Nuclear Medicine, The First Hospital of Jilin University, Changchun, Jilin Province.
Aisheng DongDepartment of Nuclear Medicine, The First Affiliated Hospital of Naval Medical University, Shanghai, China.
Hongguang ZhaoDepartment of Nuclear Medicine, The First Hospital of Jilin University, Changchun, Jilin Province.ORCID 0000-0002-9455-3743

Funding

National Nature Science Foundation of China 82102096Scientific Research Project of the Education Department of Jilin Province JJKH20231241KJScientific Research Project of the Education Department of Jilin Province JJKH20241341KJ
6 · The paper itself

Abstract

A few case reports show FAPI PET may be superior to FDG PET in evaluating angiosarcoma. We describe FDG PET/CT, delayed abdominal FDG PET/MRI, and 18 F-FAPI-04 PET/CT findings in a case of primary splenic angiosarcoma with diffuse hepatic metastases. In this case, FDG PET was superior to FAPI PET in evaluating the primary and metastatic tumors. FDG PET showed much higher activity in the primary splenic tumors compared with 18 F-FAPI-04 PET. FDG PET identified the hepatic metastases due to increased activity, which was missed on 18 F-FAPI-04 PET.

Indexed as

Fluorodeoxyglucose F18HemangiosarcomaLiver NeoplasmsOligopeptidesPositron Emission Tomography Computed TomographySplenic NeoplasmsFibroblast Activation Protein AlphaHumansFibroblast Activation Protein AlphaFluorodeoxyglucose F18OligopeptidesangiosarcomaFAPIFDGPET/CTspleen

Identifiers

PMID41805250
PMCPMC13132042

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.